A Multiple Ascending Dose Study With LY03003 in Patients With Early-stage Parkinson's Disease
Status:
Completed
Trial end date:
2019-06-21
Target enrollment:
Participant gender:
Summary
This study is to evaluate the safety and tolerability and to characterize the
pharmacokinetics of multiple ascending dose (MAD) of LY03003 following intramuscular
injections.